33
Views
9
CrossRef citations to date
0
Altmetric
Research Article

A Canine Model of Multiple Portosystemic Shunting

Pages 45-57 | Published online: 09 Jul 2009

REFERENCES

  • Boothe DM, Jenkins WL, Green RA, Corrier DE, Cullen JM, Boothe HW, Weise D. Dimethylnitrosamine-induced hepatotoxicosis in dogs as a model of progressive canine hepatic disease. Am J Vet Res. 1992;53:411–420.
  • Madden JW, Gertman PM, Peacock EE. Dimethyl-nitrosamine-induced hepatic cirrhosis: A new canine model of an ancient human disease. Surgery. 1970;68:260–268.
  • Lake BG, Collins MA, Harris RA, Phillips JC, Cottrell RC, Gangolli SD. Studies on the metabolism of dimethylni-trosamine in vitro by rat liver preparations. I. Compari-son with mixed function oxidase enzymes. Xenobiotica. 1982a;12:435–445.
  • Kroeger-Koepk e MB, Koepke SR, McClusky GA, Magee PN, Michejda CJ. Alpha-hydroxylation pathway in the in vitro metabolism of carcinogenic nitrosamines: N-Nitro-sodimethylamine and N-nitroso-N-methylaniline. Proc Natl Acad Sci USA. 1981;78:6489–6493.
  • Magee PN, Barnes JM. Carcinogenic nitroso compounds. Adv Cancer Res. 1967;10:163–247.
  • Mirvish SS. N-Nitroso compounds: Their chemical and in vivo formation and possible importance as environmen-tal carcinogens. J Toxicol Environ Health. 1977;2:1267–1277.
  • Matsuda Y, Matsumoto K, Yamada A, Ichida T, Asakura H, Komoriya Y, Nishiyama E, Nakamura T. Preventative and therapeutic effects in rats of heaptocyte growth factor infusion on liver fbrosis/cirrhosis. Hepatology. 1997;26:81–89.
  • George J, Chandrakasa n G. Glyocprotein metabolism in dimethylnitrosamine induced hepatic fbrosis in rats. Int J Biochem Cell Biol. 1996;28:353–361.
  • Testas P, Benichou J, Perrin N, Vieillefond A, Benhanou M. Comparative study of two models for experimental cirrhosis in the dog. Eur Surg Res. 1978;10:146–152.
  • Ryhanen L, Stenback F, Ala-Kokko L, Savolainen ER. The effect of malotilate on type III and type IV colla-gen, laminim and fbronectin metabolism in dimethyl-nitrosamine-induced liver fbrosis in the rat. J Hepatol. 1996;24:238–245.
  • Preussman R, Weissle M. The enigma of organ-specifcity of carcinogenic nitrosamines. Trends Pharm Sci. 1987;8:185–189.
  • Mukherjee T, Gustafsson RG, Afzelius BA, Arrhenius E. Effects of carcinogenic amines on amino acid incorpora-tion by liver systems. II. A morphologic and biochemical study on the effect of dimethylnitrosamine. Cancer Res. 1963;23:944–953.
  • Korsrud GO, Grice HG, Goodman TK, Knipfel JE, McLaughlan JM. Sensitivity of several serum enzymes for the detection of thioacetamine-, dimethylnitrosamine-and diethylolamine-induced liver damage in rats. Toxicol Appl Pharmacol. 1973;26:299–313.
  • Butler-Howe LM, Boothe HW, Boothe DM, Laine GA, Calvin JA. Effects of vena caval banding in experimen-tally induced multiple portosystemic shunts in dogs. Am J Vet Res. 1993;54:1774–1783.
  • Howe LM, Boothe DM, Boothe HW. Endotoxemia associ-ated with experimentally induced multiple portosystemic shunts in dogs. Am J Vet Res. 1997;58:83–88.
  • Boothe DM, Brown SA, Jenkins WL, Green RA, Cullen JM, Corrier DE. Indocyanine green disposition in healthy dogs and dogs with mild, moderate, or severe dimethyl-nitrosamine-induced hepatic disease. Am J Vet Res. 1992;53:382–388.
  • Wrigley RK, Konde LJ, Park RD, Lebel JL. Ultrasonographi c diagnosis of portocaval shunts in young dogs. J Am Vet Med Assoc. 1987;191:421–424.
  • Koblik PD, Hornoff WJ, Breznock EM. Quantitative hepatic scintigraphy in the dog. Vet Radiol. 1983;24:226–231.
  • Koblik PD, Hornoff WJ, Breznock EM. Use of quantita-tive hepatic scintigraphy to evaluate spontaneous por-tosystemic shunts in 12 dogs. Vet Radiol. 1983;24:232–236.
  • Moon ML. Diagnostic imaging of portosystemic shunts. Semin Vet Med Surg (Small Anim). 1990;5:120–126.
  • Butler LM, Fossum TW, Boothe HW. Surgical managemen t of extrahepatic portosystemic shunts in the dog and cat. Semin Vet Med Surg (Small Anim). 1990;5:127–133.
  • Whiting PG, Peterson SL. Portocaval shunts. In: Slatter D, ed. Textbook of Small Animal Surgery (2nd ed). Philadel-phia: WB Saunders; 1993:660–677.
  • Rozga J, Foss A, Alumets J, Ahrens B, Jeppsson B, Bengmar k S. Liver cirrhosis in rats: Regeneration and assessment of the role of phenobarbital. J Surg Res. 1991;51:329–335.
  • Doi K, Kurabe S, Shimazu N, Inagaki M. Systemic histopathology of rats with CCl4-induced hepatic cirrho-sis. Lab Anim. 1991;25:21–25.
  • Torres EM, Bouza JIP, Hernandez MMA, Martin MJA, Bravo AL. Experimental carbon tetrachloride-induced cirrhosis of the liver. Int J Tiss Reac. 1988;10:245–251.
  • Mizumoto M, Arii S, Furutani M, Nakamur a T, Ishigami S, Monden K, Ishiguro S, Fujita S, Imamura M. NO as an indicator of portal hemodynamics and the role of iNOS in increased NO production in CCl4-induced liver cirrhosis. J Surg Res. 1997;70:124–133.
  • Mion F, Geloen A, Agosto E, Minaire Y. Carbon tetrachloride-induced cirrhosis in rats: Infuence of the acute effects of the toxin on glucose metabolism. Hep-atology. 1996;23:582–588.
  • Koblik PD, Hornoff WJ, Yen C, Komtebedde J, Breznock E, Fisher P. Comparison of shunt fraction estima-tion using transcolonic iodine-123-iodoamphetamin e and technetium-99m-pertechnetate in a group of dogs with experimentally-induced chronic biliary cirrhosis. J Nuc Med. 1991;32:124–129.
  • Morgan TR, Morgan K, Jonas G, Thillainadarajah I. Atrial natriuretic factor in experimental cirrhosis in rats. Gas-troenterology. 1992;102:1356–1362.
  • Oberti F, Pilette C, Riffet H, Maiga MY, Moreau A, Gallois Y, Girault A, le Bouil A, Le Jeune JJ, Saumet JL, Feldmann G, Cales P. Effects of simvastatin, pentoxi-fylline and spironolactone on hepatic fbrosis and por-tal hypertension in rats with bile duct ligation. J Hepatol. 1997;26:1363–1371.
  • Criado M, Flores O, Ortiz MC, Hidalgo F, Rodriguez-Lopez AM, Eleno N, Atucha NM, Sanchez-Rodrigue z A, Arevalo M, Garcia-Estan J, Lopez-Novoa JM. Elevated glomeru-lar and blood mononuclear lymphocyte nitric oxide pro-duction in rats with chronic bile duct ligation: Role of inducible nitric oxide synthase activation. Hepatology. 1997;26:268–276.
  • Wong J, Zhang Y, Lee SS. Effects of portacaval shunting hyperdynamic circulation in bile duct-ligated cirrhotic rats. J Hepatol. 1997;26:369–375.
  • Awai M, Narasaki M, Yamanoi Y, Seno S. Induction of diabetes in animals by parenteral administration of fer-ric nitrilotriacetate: A model of experimental hemochro-matosis. Am J Pathol. 1979;95:663–674.
  • Toyokuni S, Okado S, Hamazaki S, Fujioka M, Li JL, Midorikawa O. Cirrhosis of the liver induced by cupric nitrilotriacetate in Wistar rats: An experimental model of copper toxicosis. Am J Pathol. 1989;134:1263–1274.
  • Muller A, Machnik F, Zimmerman T, Schubert H. Thioacetamide-induced cirrhosis-like liver lesions in rats- Usefulness and reliability of this animal model. Exp Pathol. 1988;34:229–236.
  • Buko V, Lukivskaya O, Nikitin V, Kuryan A, Dargel R. An- tioxidative effect of prostaglandin E2 in thioacetamide-induced liver cirrhosis. Exp Toxicol Pathol. 1997;49:141–146.
  • Torres MI, Fernandez MI, Gil A, Rios A. Effect of dietary nucleotides on degree of fbrosis and steatosis induced by oral intake of thioacetamide. Dig Dis Sci. 1997;42:1322–1328.
  • Terpstra OT, van Vroonhoven TJ, van Vroonhoven MV, Noordhoek J, ten Kate FJ, Wilson JH. Temporary bene-fcial effect of arterialization of the liver in cirrhotic dogs with portocaval shunt. Eur Surg Res. 1982;14:333–343.
  • Grilli S, Prodi G. Identifcation of dimethylnitrosamine metabolites in vitro. Jpn J Cancer Res. 1975;66:473–480.
  • Boothe HW, Howe LM, Edwards JF, Slater MR. Multiple ex- trahepatic portosystemic shunts in dogs: 30 Cases (1981-1993). J Am Vet Med Assoc. 1996;208:1849–1854.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.